MedTrace Logo

Potential Restoration of the Infant Microbiome

NCT02407184 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-01-12

No results posted yet for this study

Summary

Understanding the microbiome's important role in human health, the investigators wish to determine how the development of the infant microbiome is impacted by delivery mode, comparing natural vaginal birth to scheduled C-sections. Investigators will look at the oral, nasal, skin, vaginal and fecal bacteria of 78 mothers and their infants from birth to age 1.

Conditions

  • Human Microbiome

Interventions

OTHER

Newborn exposure to mother vaginal microbiota

Babies are swabbed just after delivery with gauze containing their mother's vaginal microbiota.

Sponsors & Collaborators

Principal Investigators

  • Maria Gloria Dominguez-Bello, PhD · NYU School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407184 on ClinicalTrials.gov